Dermatomyositis following the diagnosis of ovarian cancer.
We present a case history of a woman who developed dermatomyositis following the diagnosis of stage IV ovarian cancer. Dermatomyositis is a rare paraneoplastic syndrome that usually precedes the diagnosis of ovarian cancer by several months or years. Ours is the fifth reported case of dermatomyositis after an established diagnosis of ovarian cancer in the literature.
Ben-Zvi
N
N
Institute of Oncology, Kaplan Medical Center, Rehovot, Israel. nana_b@clait.org.il
Shani
A
A
Ben-Baruch
G
G
Agmon-Levin
N
N
Sthoeger
Z
Z
Huszar
M
M
Ben-Arie
A
A
Dgani
R
R
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D014408:Biomarkers, Tumor / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood; D003882:Dermatomyositis / Q000188:drug therapy / Q000209:etiology*; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D010257:Paraneoplastic Syndromes / Q000188:drug therapy / Q000209:etiology*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D007166:Immunosuppressive Agents